Publications by authors named "Fraden Bitrus"

Claim this Profile
A
A triple-blinded randomized control trial to evaluate the safety and immunogenicity of fractional doses of COVID-19 vaccines (ChAd0x1, AD26.COV2. S, and BNT162B2) among Nigeria adults: the SIFCoVAN trial.
Adesola Zaidat Musa, Abideen Olurotimi Salako, James Babatunde Ayorinde, Sabdat Ekama, Oluwatosin Olaseni Odubela, Bitrus Fraden

Trials· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Safety and immunogenicity of fractional COVID-19 vaccine doses in Nigerian adults: A randomized non-inferiority trial.
Abideen Salako, Adesola Musa, Fehintola Ige, Adam Abdullahi, Ayorinde James, Fraden Bitrus

Sci Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of fractional COVID-19 vaccine doses in Nigerian adults: A randomized non-inferiority trial.
Abideen Salako, Adesola Musa, Fehintola Ige, Adam Abdullahi, Ayorinde James, Fraden Bitrus

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of cohort event monitoring and assessment of reactogenicity and adverse events among a cohort of AstraZeneca and Moderna COVID-19 vaccine recipients in Nigeria, 2021.
Omotayo Bolu, Oluwafemi D Alo, Emem Iwara, Ashley T Longley, Ikwe Hadley, Bitrus Fraden

Vaccine· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in Adverse Event Reporting Before and After the Introduction of the Med Safety App in Nigeria.
Uchenna Geraldine Elemuwa, Fraden Bitrus, Ibrahim Adekunle Oreagba, Adeline Ijeoma Osakwe, Abiola Sadikat Abiodun

Pharmaceut Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis